torcetrapib has been researched along with Genetic Predisposition in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barter, P | 1 |
| Barter, PJ | 1 |
| Mombelli, G; Sirtori, CR | 1 |
3 other study(ies) available for torcetrapib and Genetic Predisposition
| Article | Year |
|---|---|
Lessons learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial.
Topics: Animals; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Early Termination of Clinical Trials; Genetic Predisposition to Disease; Humans; Quinolines; Randomized Controlled Trials as Topic | 2009 |
The relationship between cholesteryl ester transfer protein and cardiovascular risk.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Cholesterol Ester Transfer Proteins; Genetic Predisposition to Disease; Humans; Polymorphism, Genetic; Quinolines; Risk | 2010 |
Cholesteryl ester transfer protein antagonism by drugs--a poor choice.
Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Cholesterol Ester Transfer Proteins; Clinical Trials as Topic; Coronary Disease; Drug Therapy, Combination; Genetic Predisposition to Disease; Heptanoic Acids; Humans; Polymorphism, Genetic; Pyrroles; Quinolines; Risk | 2010 |